| A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer S Paik, S Shak, G Tang, C Kim, J Baker, M Cronin, FL Baehner, ... New England Journal of Medicine 351 (27), 2817-2826, 2004 | 7183 | 2004 |
| Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor–positive breast cancer S Paik, G Tang, S Shak, C Kim, J Baker, W Kim, M Cronin, FL Baehner, ... Journal of clinical oncology 24 (23), 3726-3734, 2006 | 3120 | 2006 |
| HER2 Status and Benefit from Adjuvant Trastuzumab in Breast Cancer S Paik, C Kim, N Wolmark New England Journal of Medicine 358 (13), 1409-1411, 2008 | 527 | 2008 |
| Mutation profiling and microsatellite instability in stage II and III colon cancer: an assessment of their prognostic and oxaliplatin predictive value PG Gavin, LH Colangelo, D Fumagalli, N Tanaka, MY Remillard, ... Clinical cancer research 18 (23), 6531-6541, 2012 | 341 | 2012 |
| Gene-expression-based prognostic assays for breast cancer C Kim, S Paik Nature reviews Clinical oncology 7 (6), 340-347, 2010 | 175 | 2010 |
| Estrogen receptor (ESR1) mRNA expression and benefit from tamoxifen in the treatment and prevention of estrogen receptor–positive breast cancer C Kim, G Tang, KL Pogue-Geile, JP Costantino, FL Baehner, J Baker, ... Journal of clinical oncology 29 (31), 4160, 2011 | 138 | 2011 |
| Multi-gene RT-PCR assay for predicting recurrence in node negative breast cancer patients-NSABP studies B-20 and B-14 S Paik, S Shak, G Tang, C Kim, J Baker, M Cronin, R Baehner, M Walker, ... Breast Cancer Research and Treatment 82, S10-S11, 2003 | 124 | 2003 |
| Predicting degree of benefit from adjuvant trastuzumab in NSABP trial B-31 KL Pogue-Geile, C Kim, JH Jeong, N Tanaka, H Bandos, PG Gavin, ... Journal of the National Cancer Institute 105 (23), 1782-1788, 2013 | 121 | 2013 |
| Evaluation of microtubule-associated protein-Tau expression as a prognostic and predictive marker in the NSABP-B 28 randomized clinical trial L Pusztai, JH Jeong, Y Gong, JS Ross, C Kim, S Paik, R Rouzier, F Andre, ... Journal of clinical oncology 27 (26), 4287, 2009 | 116 | 2009 |
| Methods of whole genome or microarray expression profiling using nucleic acids prepared from formalin fixed paraffin embedded tissue S Paik, K Pogue-Geile, C Kim US Patent App. 11/796,752, 2007 | 111 | 2007 |
| Technology insight: Application of molecular techniques to formalin-fixed paraffin-embedded tissues from breast cancer S Paik, C Kim, Y Song, W Kim Nature Clinical Practice Oncology 2 (5), 246-254, 2005 | 104 | 2005 |
| Expression of the 21 genes in the Recurrence Score assay and tamoxifen clinical benefit in the NSABP study B-14 of node negative, estrogen receptor positive breast cancer S Paik, S Shak, G Tang, C Kim, J Baker, M Cronin, D Watson, J Bryant, ... Journal of Clinical Oncology 23 (16_suppl), 510-510, 2005 | 100 | 2005 |
| Immunohistochemistry and fluorescence in situ hybridization assessment of HER2 in clinical trials of adjuvant therapy for breast cancer (NCCTG N9831, BCIRG 006, and BCIRG 005) EA Perez, MF Press, AC Dueck, RB Jenkins, C Kim, B Chen, I Villalobos, ... Breast Cancer Research and Treatment 138, 99-108, 2013 | 99 | 2013 |
| Benefit from adjuvant trastuzumab may not be confined to patients with IHC 3+ and/or FISH-positive tumors: Central testing results from NSABP B-31 S Paik, C Kim, J Jeong, CE Geyer, EH Romond, O Mejia-Mejia, ... Journal of Clinical Oncology 25 (18_suppl), 511-511, 2007 | 95 | 2007 |
| Trastuzumab sensitivity of breast cancer with co-amplification of HER2 and cMYC suggests pro-apoptotic function of dysregulated cMYC in vivo. C Kim, J Bryant, Z Horne, CE Geyer, DL Wickerham, N Wolmark, S Paik Breast cancer research and treatment 94, S6-S7, 2005 | 89 | 2005 |
| Expression of the 21 genes in the Recurrence Score assay and prediction of clinical benefit from tamoxifen in NSABP study B-14 and chemotherapy in NSABP study B-20 S Paik, S Shak, G Tang, C Kim, H Joo, J Baker, M Cronin, D Watson, ... Breast Cancer Research and Treatment 88, S15-S15, 2004 | 79 | 2004 |
| Akt phosphorylation at Ser473 predicts benefit of paclitaxel chemotherapy in node-positive breast cancer SX Yang, JP Costantino, C Kim, EP Mamounas, D Nguyen, JH Jeong, ... Journal of Clinical Oncology 28 (18), 2974, 2010 | 75 | 2010 |
| Chemosensitivity and stratification by a five monoclonal antibody immunohistochemistry test in the NSABP B14 and B20 trials DT Ross, C Kim, G Tang, OL Bohn, RA Beck, BZ Ring, RS Seitz, S Paik, ... Clinical cancer research 14 (20), 6602-6609, 2008 | 74 | 2008 |
| Biomarker discovery for colon cancer using a 761 gene RT-PCR assay KM Clark-Langone, JY Wu, C Sangli, A Chen, JL Snable, A Nguyen, ... BMC genomics 8, 1-18, 2007 | 64 | 2007 |
| Anticancer effect of metformin on estrogen receptor-positive and tamoxifen-resistant breast cancer cell lines J Kim, J Lee, SY Jang, C Kim, Y Choi, A Kim Oncology reports 35 (5), 2553-2560, 2016 | 44 | 2016 |
